SAN FRANCISCO - A federal appeals panel on March 4 affirmed the conviction and sentencing of former InterMune Inc. CEO W. Scott Harkonen, M.D., for wire fraud for issuing a press release that fraudulently described clinical study results for the company's former interferon drug Actimmune (United State of America v. W. Scott Harkonen, M.D., Nos. 11-10209 and 11-10242, 9th Cir.; 2013 U.S. App. LEXIS 4472; See 4/21/11, Page 6)....(read more)![]()
↧